From Earlier: Momenta Pharmaceuticals Announces Decision in Teva Patent Litigation

Momenta Pharmaceuticals, Inc. MNTA on Friday announced that the District Court for the Southern District of New York has issued a decision in the patent litigation brought against Momenta by Teva in August of 2008. The court found all the claims infringed and not invalid or unenforceable. The decision is subject to appeal.